San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

HLI Just Snatched Up 4 GE Execs

San Diego’s growing health intelligence company, Human Longevity Inc., has recruited four executives from GE Healthcare to lead the company’s commercialization efforts.

By Brittany Meiling May 3, 2017 1:41 p.m. share »

Orexigen Subsidiary Signs Deal With Swedish Distributor

A subsidiary of local drugmaker Orexigen Therapeutics Inc. has signed a deal with Navamedic AB, a Swedish distributor, to commercialize one of its products in five Nordic countries.

By Brittany Meiling May 2, 2017 1:03 p.m. share »

Big Pharma Execs Join Renova Leadership Team

Renova Therapeutics Inc., a local biotech developing gene and peptide therapies, has recruited two Big Pharma executives to join the biotech’s leadership team.

By Brittany Meiling May 2, 2017 10:53 a.m. share »

Senomyx Inc. Posts Q1 Revenue of $4.47 Million

Earnings for Senomyx Inc., a local biotech that makes flavor enhancers, have beat Wall Street’s expectations, according to the company’s financial statements.

May 1, 2017 4:55 p.m. share »

ResMed Q3 Revenue of $514.2 Million Misses Expectations

The stock price for San Diego’s ResMed Inc. is down 4.5 percent since Friday’s quarterly earnings report, which showed the medical device maker’s sales below Wall Street’s expectations.

By Brittany Meiling May 1, 2017 3:21 p.m. share »

TNK Therapeutics Inc. to Acquire Scotland-Based Co. in Potential $34.4M Deal

TNK Therapeutics Inc., a subsidiary of San Diego’s Sorrento Therapeutics Inc., is acquiring Scotland-based Virttu Biologics in a stock deal worth up to $34.4 million.

By Brittany Meiling April 28, 2017 4:26 p.m. share »

ChromaCode Raises $12 Million in Series B Round

ChromaCode Inc., a molecular information startup in San Diego, has raised $12 million in a Series B funding and appointed a former Illumina executive as the company’s executive chairman.

By Brittany Meiling April 27, 2017 3:48 p.m. share »

AltheaDx Inc. Raises $27 Million in Series D Funding

San Diego molecular information firm AltheaDx Inc. has raised $27 million in a Series D funding, the company announced.

By Sarah de Crescenzo April 27, 2017 2:24 p.m. share »

Why Tocagen Raised $98M

Last month, San Diego drugmaker Tocagen Inc. raised $98 million in the largest initial public offering San Diego has seen in a few years.

By Brittany Meiling April 27, 2017 12:58 p.m. share »
Tease photo

Bug Busters Forge on with $15M in Startup Capital

Forge Therapeutics Inc., a biotech startup that’s waging war on super bugs, just got armed with $15 million in fresh capital to fuel its research.

By Brittany Meiling April 27, 2017 12:57 p.m. share »
Tease photo

Takeaways From the Man Behind San Diego’s $12B Biotech

Osman Kibar has history in San Diego. As a graduate student at the University of California, San Diego, he played a role in founding two startups, including Carlsbad-based Genoptix Inc., though he didn’t have a management role in either.

By Sarah de Crescenzo April 27, 2017 12:31 p.m. share »

Neurocrine Announces $450 Million Convertible Senior Notes Offering

San Diego drugmaker Neurocrine Biosciences Inc. is raising up to $502 million in an offering of convertible senior notes, the company announced Wednesday.

By Brittany Meiling April 27, 2017 10:53 a.m. share »
Tease photo

5 Takeaways From the Man Behind S.D.’s $12B Biotech

Osman Kibar, the founder and CEO of Samumed LLC, shares some of what he's learned about science, medicine and commerce.

By Sarah de Crescenzo April 26, 2017 5:08 p.m. share »

Q1 Earnings Show NuVasive's Strong Financial Position

San Diego medical device maker NuVasive Inc. met Wall Street’s expectations in the first quarter with revenue up 16 percent to $250 million.

By Brittany Meiling April 26, 2017 3:51 p.m. share »
Tease photo

Here’s How Much Illumina’s 5 Highest-Paid Executives Earned

The five highest-paid executives at Illumina Inc. each pulled in over $2 million in compensation last year, with an average of $4 million each.

By Brittany Meiling April 26, 2017 3:11 p.m. share »